Surface Roughness Characterisation and Analysis of the Electron Beam Melting (EBM) Process.

Electron Beam Melting (EBM) is a metal powder bed fusion (PBF) process in which the heat source is an electron beam. Differently from other metal PBF processes, today, EBM is used for mass production. As-built EBM parts are clearly recognisable by their surface roughness, which is, in some cases, one of the major limitations of the EBM process. The aim of this work is to investigate the effects of the orientation and the slope of the EBM surfaces on the surface roughness. Additionally, the machine repeatability is studied by measuring the roughness of surfaces built at different positions on the start plate.
To these aims, a specific artefact was designed. Replicas of the artefact were produced using an Arcam A2X machine and Ti6Al4V powder. Descriptive and inferential statistical methods were applied to investigate whether the surface morphology was affected by process factors. The results show significant differences between the upward and downward surfaces. The upward surfaces appear less rough than the downward ones, for which a lower standard deviation was obtained in the results. The roughness of the upward surfaces is linearly influenced by the sloping angle, while the heat distribution on the cross-section was found to be a key factor in explaining the roughness of the downward surfaces.

Reviewing the Mechanistic Evidence Assessors E-Synthesis and EBM+: A Case Study of Amoxicillin and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

Basic science has delivered unprecedented insights into intricate relationships on the smallest scales within well-controlled environments. Addressing pressing societal decision problems requires an understanding of systems on larger scales in real-world situations.To assess how well the evidence assessors E-Synthesis and EBM+ assess basic science findings to support medical decision making.We demonstrate the workings of E-Synthesis and B
M+ on a case study: the suspected causal connection between the widely-used drug amoxicillin (AMX) and the putative adverse drug reaction: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).We determine an increase in the probability that AMX can cause DRESS within the E-Synthesis approach and using the EBM+ standards assess the basic science findings as supporting the existence of a mechanism linking AMX and DRESS.
While progress is made towards developing methodologies which allow the incorporation of basic science research in the decision-making process for pressing societal questions, there is still considerable need for further developments. A continued dialogue between basic science researchers and methodologists, philosophers and statisticians seems to offer the best prospects for developing and evaluating continuously evolving methodologies.

The Effect of EBM Process Parameters on Porosity and Microstructure of Ti-5Al-5Mo-5V-1Cr-1Fe Alloy.

In this article, the authors discuss the results of studies into the processing of Ti-5Al-5Mo-5V-1Cr-1Fe near-β titanium alloy (Ti-55511) by electron beam melting (EBM), an additive manufacturing technique. Due to its high flexibility in shaping mechanical properties, Ti-55511 alloy is commonly used in aircraft components such as landing gear or airframes. In this study, Ti-55511 powder was used and its properties were described as regards chemical composition and particle size distribution in order to assess its suitability for EBM processing and repeatability of results. 20 sets of processing parameters were tested in the energy input range between 10 J/mm3 and 50 J/mm3 (cathode current, 4.5 mA-19.5 mA; scanning speed, 1080 mm/s-23400 mm/s).
 Surface Roughness Characterisation and Analysis of the Electron Beam Melting (EBM) Process.
Four types of top surfaces were obtained, namely, flat, orange peel, with single pores, and with swelling. Best results were obtained for the energy of 30 J/mm3: flat top surface and relative density in excess of 99.9%. Analysis of chemical composition showed that aluminum loss was below the specification minimum for the analyzed parameter sets. Scanning speed most significantly affected aluminum content: the lower the scanning speed, the higher the aluminum loss.
Analysis of microstructures showed the dependence of lamellar α-phase volume fraction on the process parameters used. For low scanning speed, the determined α-phase volume accounted for about 78%. Higher scanning speed resulted in a decrease of the α-phase content to 61%. The dimensions of the lamellas and the amount of the α-phase strongly effected hardness results (360 HV to 430 HV).

EBM II: How to perform a literature search.

The present article is a second part related to evidence based medicine (EBM) in a series of five by the European society for paediatric urology (ESPU) research committee. It will present the different databases/search engines available to clinicians and researchers and describe strategies to focus the search to one’s particular needs. Indeed, databases/search engines used and search strategy should vary according to the goal of the research.
If the aim is to address a clinical problem, the search should allow to identify a small number of most pertinent articles (high specificity); if the search is for research purposes, instead, it should ensure no meaningful articles are overlooked (high sensitivity).

Superior Wear Resistance in EBM-Processed TC4 Alloy Compared with SLM and Forged Samples.

The wear properties of Ti-6Al-4V alloy have drawn great attention in both aerospace and biomedical fields. The present study examines the wear properties of Ti-6Al-4V alloy as prepared by selective laser melting (SLM), electron beam melting (EBM) and conventional forging processes. The SLM and EBM samples show better wear resistance than the forged sample, which correlates to their higher hardness values and weak delamination tendencies.

A2M 3'UTR Luciferase Stable Cell Line

TU000005 1.0 ml
EUR 1394

A2ML1 3'UTR Luciferase Stable Cell Line

TU000006 1.0 ml
EUR 1394

A2MP1 3'UTR Luciferase Stable Cell Line

TU000007 1.0 ml
EUR 2333

A3GALT2 3'UTR Luciferase Stable Cell Line

TU000008 1.0 ml
EUR 2333

A4GALT 3'UTR Luciferase Stable Cell Line

TU000009 1.0 ml
EUR 1394

A4GNT 3'UTR Luciferase Stable Cell Line

TU000010 1.0 ml
EUR 1394

AAAS 3'UTR Luciferase Stable Cell Line

TU000011 1.0 ml
EUR 1394

AACP 3'UTR Luciferase Stable Cell Line

TU000012 1.0 ml
EUR 2333

AACS 3'UTR Luciferase Stable Cell Line

TU000013 1.0 ml
EUR 1394

AACSL 3'UTR Luciferase Stable Cell Line

TU000014 1.0 ml
EUR 2333

AADAC 3'UTR Luciferase Stable Cell Line

TU000015 1.0 ml
EUR 1394

AADACL2 3'UTR Luciferase Stable Cell Line

TU000016 1.0 ml
EUR 2333

AADACL3 3'UTR Luciferase Stable Cell Line

TU000017 1.0 ml
EUR 1521

AADACL4 3'UTR Luciferase Stable Cell Line

TU000018 1.0 ml
EUR 1394

AADAT 3'UTR Luciferase Stable Cell Line

TU000019 1.0 ml
EUR 1394

AAGAB 3'UTR Luciferase Stable Cell Line

TU000020 1.0 ml
EUR 2333

AAK1 3'UTR Luciferase Stable Cell Line

TU000021 1.0 ml
EUR 1521

AAMP 3'UTR Luciferase Stable Cell Line

TU000022 1.0 ml
EUR 1394

AANAT 3'UTR Luciferase Stable Cell Line

TU000023 1.0 ml
EUR 1394

AARS 3'UTR Luciferase Stable Cell Line

TU000024 1.0 ml
EUR 1394

AARS2 3'UTR Luciferase Stable Cell Line

TU000025 1.0 ml
EUR 1394

AARSD1 3'UTR Luciferase Stable Cell Line

TU000026 1.0 ml
EUR 1394

AASDH 3'UTR Luciferase Stable Cell Line

TU000027 1.0 ml
EUR 1521

AASDHPPT 3'UTR Luciferase Stable Cell Line

TU000028 1.0 ml
EUR 1521

AASS 3'UTR Luciferase Stable Cell Line

TU000029 1.0 ml
EUR 2333

AATF 3'UTR Luciferase Stable Cell Line

TU000030 1.0 ml
EUR 1394

AATK 3'UTR Luciferase Stable Cell Line

TU000031 1.0 ml
EUR 1521

ABAT 3'UTR Luciferase Stable Cell Line

TU000033 1.0 ml
EUR 2333

ABCA1 3'UTR Luciferase Stable Cell Line

TU000034 1.0 ml
EUR 2333

ABCA2 3'UTR Luciferase Stable Cell Line

TU000035 1.0 ml
EUR 4617

ABCA3 3'UTR Luciferase Stable Cell Line

TU000036 1.0 ml
EUR 4617

ABCA4 3'UTR Luciferase Stable Cell Line

TU000037 1.0 ml
EUR 1394

ABCA5 3'UTR Luciferase Stable Cell Line

TU000038 1.0 ml
EUR 2333

ABCA6 3'UTR Luciferase Stable Cell Line

TU000039 1.0 ml
EUR 2333

ABCA7 3'UTR Luciferase Stable Cell Line

TU000040 1.0 ml
EUR 1394

ABCA8 3'UTR Luciferase Stable Cell Line

TU000041 1.0 ml
EUR 2333

ABCA9 3'UTR Luciferase Stable Cell Line

TU000042 1.0 ml
EUR 1521

ABCA10 3'UTR Luciferase Stable Cell Line

TU000043 1.0 ml
EUR 2333

ABCA12 3'UTR Luciferase Stable Cell Line

TU000045 1.0 ml
EUR 1394

ABCA13 3'UTR Luciferase Stable Cell Line

TU000046 1.0 ml
EUR 2333

ABCB1 3'UTR Luciferase Stable Cell Line

TU000048 1.0 ml
EUR 2333

ABCB4 3'UTR Luciferase Stable Cell Line

TU000049 1.0 ml
EUR 1394

ABCB5 3'UTR Luciferase Stable Cell Line

TU000050 1.0 ml
EUR 1394

ABCB6 3'UTR Luciferase Stable Cell Line

TU000051 1.0 ml
EUR 1521

ABCB7 3'UTR Luciferase Stable Cell Line

TU000052 1.0 ml
EUR 1521

ABCB8 3'UTR Luciferase Stable Cell Line

TU000053 1.0 ml
EUR 2333

ABCB9 3'UTR Luciferase Stable Cell Line

TU000054 1.0 ml
EUR 1394

ABCB10 3'UTR Luciferase Stable Cell Line

TU000055 1.0 ml
EUR 1521

ABCB10P1 3'UTR Luciferase Stable Cell Line

TU000056 1.0 ml
EUR 2333

ABCB10P2 3'UTR Luciferase Stable Cell Line

TU000057 1.0 ml
EUR 2333

ABCB10P3 3'UTR Luciferase Stable Cell Line

TU000058 1.0 ml
EUR 2333

ABCB10P4 3'UTR Luciferase Stable Cell Line

TU000059 1.0 ml
EUR 2333

ABCB11 3'UTR Luciferase Stable Cell Line

TU000060 1.0 ml
EUR 1521

ABCC1 3'UTR Luciferase Stable Cell Line

TU000061 1.0 ml
EUR 1521

ABCC2 3'UTR Luciferase Stable Cell Line

TU000062 1.0 ml
EUR 1394

ABCC3 3'UTR Luciferase Stable Cell Line

TU000063 1.0 ml
EUR 2333

ABCC4 3'UTR Luciferase Stable Cell Line

TU000064 1.0 ml
EUR 1521

ABCC5 3'UTR Luciferase Stable Cell Line

TU000065 1.0 ml
EUR 2333

ABCC6 3'UTR Luciferase Stable Cell Line

TU000066 1.0 ml
EUR 1521

ABCC6P1 3'UTR Luciferase Stable Cell Line

TU000067 1.0 ml
EUR 2333

ABCC6P2 3'UTR Luciferase Stable Cell Line

TU000068 1.0 ml
EUR 2333

ABCC8 3'UTR Luciferase Stable Cell Line

TU000069 1.0 ml
EUR 1521

ABCC9 3'UTR Luciferase Stable Cell Line

TU000070 1.0 ml
EUR 2333

ABCC10 3'UTR Luciferase Stable Cell Line

TU000071 1.0 ml
EUR 1394

ABCC11 3'UTR Luciferase Stable Cell Line

TU000072 1.0 ml
EUR 1394

ABCC12 3'UTR Luciferase Stable Cell Line

TU000073 1.0 ml
EUR 1521

ABCC13 3'UTR Luciferase Stable Cell Line

TU000074 1.0 ml
EUR 2333

ABCD1 3'UTR Luciferase Stable Cell Line

TU000075 1.0 ml
EUR 1394

ABCD1P1 3'UTR Luciferase Stable Cell Line

TU000076 1.0 ml
EUR 2333

ABCD1P2 3'UTR Luciferase Stable Cell Line

TU000077 1.0 ml
EUR 2333

ABCD1P3 3'UTR Luciferase Stable Cell Line

TU000078 1.0 ml
EUR 2333

ABCD1P4 3'UTR Luciferase Stable Cell Line

TU000079 1.0 ml
EUR 2333

ABCD2 3'UTR Luciferase Stable Cell Line

TU000080 1.0 ml
EUR 1521

ABCD3 3'UTR Luciferase Stable Cell Line

TU000081 1.0 ml
EUR 1521

ABCD4 3'UTR Luciferase Stable Cell Line

TU000082 1.0 ml
EUR 1521

ABCE1 3'UTR Luciferase Stable Cell Line

TU000083 1.0 ml
EUR 1521

ABCF1 3'UTR Luciferase Stable Cell Line

TU000084 1.0 ml
EUR 1394

ABCF2 3'UTR Luciferase Stable Cell Line

TU000085 1.0 ml
EUR 1521

ABCF3 3'UTR Luciferase Stable Cell Line

TU000086 1.0 ml
EUR 1394

ABCG1 3'UTR Luciferase Stable Cell Line

TU000087 1.0 ml
EUR 2333

ABCG2 3'UTR Luciferase Stable Cell Line

TU000088 1.0 ml
EUR 1521

ABCG4 3'UTR Luciferase Stable Cell Line

TU000089 1.0 ml
EUR 1521

ABCG5 3'UTR Luciferase Stable Cell Line

TU000090 1.0 ml
EUR 1521

ABCG8 3'UTR Luciferase Stable Cell Line

TU000091 1.0 ml
EUR 1394

ABHD1 3'UTR Luciferase Stable Cell Line

TU000092 1.0 ml
EUR 1394

ABHD2 3'UTR Luciferase Stable Cell Line

TU000093 1.0 ml
EUR 4617

ABHD3 3'UTR Luciferase Stable Cell Line

TU000094 1.0 ml
EUR 1394

ABHD4 3'UTR Luciferase Stable Cell Line

TU000095 1.0 ml
EUR 1521

ABHD5 3'UTR Luciferase Stable Cell Line

TU000096 1.0 ml
EUR 1394

ABHD6 3'UTR Luciferase Stable Cell Line

TU000097 1.0 ml
EUR 1394

ABHD8 3'UTR Luciferase Stable Cell Line

TU000098 1.0 ml
EUR 1394

ABHD10 3'UTR Luciferase Stable Cell Line

TU000099 1.0 ml
EUR 1521

ABHD11 3'UTR Luciferase Stable Cell Line

TU000100 1.0 ml
EUR 1394

ABHD12 3'UTR Luciferase Stable Cell Line

TU000101 1.0 ml
EUR 1394

ABHD12B 3'UTR Luciferase Stable Cell Line

TU000102 1.0 ml
EUR 1394

ABHD13 3'UTR Luciferase Stable Cell Line

TU000103 1.0 ml
EUR 2333
The EBM sample shows a lower wear rate than the SLM sample because of the formation of multiple horizontal cracks in the SLM sample, which results in heavier delamination. The results suggest that additive manufacturing processes offer significantly wear-resistant Ti-6Al-4V specimens in comparison to their counterparts produced by forging.